SANA logo

Sana Biotechnology, Inc. (SANA) Cash From Financing

Annual CFF:

$199.75M+$168.10M(+531.20%)
December 31, 2024

Summary

  • As of today, SANA annual cash from financing is $199.75 million, with the most recent change of +$168.10 million (+531.20%) on December 31, 2024.
  • During the last 3 years, SANA annual cash from financing has fallen by -$432.00 million (-68.38%).
  • SANA annual cash from financing is now -68.38% below its all-time high of $631.75 million, reached on December 31, 2021.

Performance

SANA Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSANAcash flow metrics

Quarterly CFF:

$109.54M+$108.98M(+19425.85%)
September 30, 2025

Summary

  • As of today, SANA quarterly cash from financing is $109.54 million, with the most recent change of +$108.98 million (+19425.85%) on September 30, 2025.
  • Over the past year, SANA quarterly cash from financing has increased by +$107.46 million (+5161.29%).
  • SANA quarterly cash from financing is now -82.52% below its all-time high of $626.70 million, reached on March 31, 2021.

Performance

SANA Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSANAcash flow metrics

TTM CFF:

$111.73M+$107.46M(+2517.76%)
September 30, 2025

Summary

  • As of today, SANA TTM cash from financing is $111.73 million, with the most recent change of +$107.46 million (+2517.76%) on September 30, 2025.
  • Over the past year, SANA TTM cash from financing has dropped by -$89.10 million (-44.37%).
  • SANA TTM cash from financing is now -82.31% below its all-time high of $631.75 million, reached on December 31, 2021.

Performance

SANA TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSANAcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

SANA Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+531.2%+5161.3%-44.4%
3Y3 Years-68.4%+6657.6%+1502.7%
5Y5 Years-10.7%+10000.0%+10000.0%

SANA Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-68.4%+3965.7%-41.2%>+9999.0%-48.7%+2517.8%
5Y5-Year-68.4%+3965.7%-82.5%>+9999.0%-82.3%>+9999.0%
All-TimeAll-Time-68.4%+3965.7%-82.5%>+9999.0%-82.3%>+9999.0%

SANA Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$109.54M(>+9900.0%)
$111.73M(+2517.8%)
Jun 2025
-
$561.00K(-42.9%)
$4.27M(-70.2%)
Mar 2025
-
$982.00K(+52.7%)
$14.33M(-92.8%)
Dec 2024
$199.75M(+531.2%)
$643.00K(-69.1%)
$199.75M(-0.5%)
Sep 2024
-
$2.08M(-80.4%)
$200.82M(+1.0%)
Jun 2024
-
$10.63M(-94.3%)
$198.93M(-8.7%)
Mar 2024
-
$186.40M(>+9900.0%)
$217.81M(+588.3%)
Dec 2023
$31.65M(+544.1%)
$1.72M(+818.7%)
$31.65M(+2.1%)
Sep 2023
-
$187.00K(-99.4%)
$30.99M(-4.4%)
Jun 2023
-
$29.50M(>+9900.0%)
$32.42M(+621.0%)
Mar 2023
-
$236.00K(-77.8%)
$4.50M(-8.5%)
DateAnnualQuarterlyTTM
Dec 2022
$4.91M(-99.2%)
$1.06M(-34.5%)
$4.91M(-29.5%)
Sep 2022
-
$1.62M(+2.7%)
$6.97M(+0.4%)
Jun 2022
-
$1.58M(+142.2%)
$6.95M(+21.9%)
Mar 2022
-
$652.00K(-79.1%)
$5.70M(-99.1%)
Dec 2021
$631.75M(+45.0%)
$3.12M(+95.4%)
$631.75M(+0.5%)
Sep 2021
-
$1.60M(+379.3%)
$628.74M(+0.3%)
Jun 2021
-
$333.00K(-99.9%)
$627.14M(+0.1%)
Mar 2021
-
$626.70M(>+9900.0%)
$626.81M(>+9900.0%)
Dec 2020
$435.69M(+94.7%)
$103.00K
$103.00K
Dec 2019
$223.73M(+389.3%)
-
-
Dec 2018
$45.72M
-
-

FAQ

  • What is Sana Biotechnology, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Sana Biotechnology, Inc.?
  • What is Sana Biotechnology, Inc. annual cash from financing year-on-year change?
  • What is Sana Biotechnology, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Sana Biotechnology, Inc.?
  • What is Sana Biotechnology, Inc. quarterly cash from financing year-on-year change?
  • What is Sana Biotechnology, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Sana Biotechnology, Inc.?
  • What is Sana Biotechnology, Inc. TTM cash from financing year-on-year change?

What is Sana Biotechnology, Inc. annual cash from financing?

The current annual cash from financing of SANA is $199.75M

What is the all-time high annual cash from financing for Sana Biotechnology, Inc.?

Sana Biotechnology, Inc. all-time high annual cash from financing is $631.75M

What is Sana Biotechnology, Inc. annual cash from financing year-on-year change?

Over the past year, SANA annual cash from financing has changed by +$168.10M (+531.20%)

What is Sana Biotechnology, Inc. quarterly cash from financing?

The current quarterly cash from financing of SANA is $109.54M

What is the all-time high quarterly cash from financing for Sana Biotechnology, Inc.?

Sana Biotechnology, Inc. all-time high quarterly cash from financing is $626.70M

What is Sana Biotechnology, Inc. quarterly cash from financing year-on-year change?

Over the past year, SANA quarterly cash from financing has changed by +$107.46M (+5161.29%)

What is Sana Biotechnology, Inc. TTM cash from financing?

The current TTM cash from financing of SANA is $111.73M

What is the all-time high TTM cash from financing for Sana Biotechnology, Inc.?

Sana Biotechnology, Inc. all-time high TTM cash from financing is $631.75M

What is Sana Biotechnology, Inc. TTM cash from financing year-on-year change?

Over the past year, SANA TTM cash from financing has changed by -$89.10M (-44.37%)
On this page